GBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inovio Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.557 EUR -25.08% Market Closed

Market Cap: €38.3m

	Inovio Pharmaceuticals Inc F:GBM	US
U	Universal Technical Institute Inc F:UTI	US
R	Realtech AG XBER:RTC	DE
A	Albany International Corp F:AII	US
	City Developments Ltd F:CDE0	SG
	Siti Networks Ltd BSE:532795	IN
G	Greatland Gold PLC XMUN:U0Y	AU
D	Dermapharm Holding SE XHAM:DMP	DE
C	CBIZ Inc F:XC4	US
G	Geron Corp F:GON	US
A	American States Water Co XMUN:FDK	US
	Bukit Sembawang Estates Ltd SGX:B61	SG
B	Bed Bath & Beyond Inc F:BBY	US
V	Vallourec SA PAR:VK	FR

Profitability Summary

Inovio Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-45 463%

Low Net Margin

Negative 3Y Average Net Margin

-44 925%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-44 203%

Negative ROE

-296%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-638%

ROIC is Increasing

-1 045% > -713%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.